NEW THERAPY OFFERS HOPE FOR BONE MARROW CANCER

Published:2019-05-03


A new therapy developed by Chinese researchers to treat bone marrow cancer has completed its first phase of clinical trials with a response rate of 90 percent.


The high response rate suggests the therapy might significantly raise the five-year survival rate of patients with multiple myeloma, which currently stands at 50.7 percent.

SITE MAP

World Time

  • SENEGAL | DAKAR:08.15 12:21

  • NIGERIA | LAGOS:08.15 13:21

  • EGYPT | CAIRO:08.15 14:21

  • UAE | DUBAI:08.15 16:21

  • SRI LANKA | COLOMBO:08.15 17:51

  • SINGAPORE:08.15 20:21

  • ENGLAND | LONDON:08.15 13:21

  • RUSSIA | MOSCOW:08.15 16:21

  • CHINA | BEIJING:08.15 20:21

  • AMERICA | Los Angels:08.15 05:21

  • AMERICA | New York:08.15 08:21

  • BRAZIL | San Paulo:08.15 09:21